Medical Research News

RSS

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers in the Abramson Cancer Center of the University of Pennsylvania published in JCI Insight.

4 Feb 2021

Research shows how air pollution has a detrimental impact on cardiovascular health

Tiny particles of air pollution -- called fine particulate matter -- can have a range of effects on health, and exposure to high levels is a known risk factor for cardiovascular disease.

4 Feb 2021

Seasonal flu shots reduce COVID-19 symptoms in children

Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020.

4 Feb 2021

Researchers call for trials of rapamycin to treat COVID-19

Researchers in the United States, China, and the UK have called for immediate large-scale clinical trials of an antibiotic called rapamycin as a prophylactic and treatment approach to coronavirus disease 2019 (COVID-19) in older individuals.

4 Feb 2021

New guidance can help cardiac patients with diabetes to exercise more safely

Cardiac patients who also have diabetes will be able to do their rehabilitation exercises more safely, thanks to the world's first guidance on the subject, which has been published by international experts including a Swansea University academic.

4 Feb 2021

School gardens may get children to eat more vegetables

Getting children to eat their vegetables can seem like an insurmountable task, but nutrition researchers at The University of Texas at Austin have found one way: school gardens and lessons on using what's grown in them.

4 Feb 2021

Phase I/II trial findings support use of CoronaVac vaccine in older individuals

Researchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

4 Feb 2021

Race may play an important role in children's food allergies

Black children have significantly higher rates of shellfish and fish allergies than White children, in addition to having higher odds of wheat allergy, suggesting that race may play an important role in how children are affected by food allergies, researchers at Ann & Robert H. Lurie Children's Hospital of Chicago, Rush University Medical Center and two other hospitals have found.

4 Feb 2021

New study to examine stress, cancer risk and reproductive toxicity in women firefighters

Researchers at the University of Arizona Health Sciences are undertaking a study to better understand the potential enviromental and occupational health risks specific to women in the fire service.

4 Feb 2021

People with borderline personality disorder may have difficulty in accessing health services

Borderline Personality Disorder, or BPD, is the most common personality disorder in Australia, affecting up to 5% of the population at some stage, and Flinders University researchers warn more needs to be done to meet this high consumer needs.

4 Feb 2021

New study supports UK’s delay of the SARS-CoV-2 Pfizer vaccine second dose

After reanalyzing data from 500,000 people in Israel who received the Pfizer vaccine, researchers suggest a single dose provides sufficient immunity after about 21 days, thus providing support for the UK’s decision to delay the second dose to 12 weeks.

4 Feb 2021

Cancer patients less likely to receive life-saving therapy when suffering a heart attack

A major study of nearly 2 million heart attack patients has found that many who also had cancer were not offered a potentially lifesaving treatment, despite the fact it had major benefits.

4 Feb 2021

Researchers develop thermostable RNA vaccine delivery platform

A new study describes the production of a new RNA vaccine delivery system that promises greater ease of storage and distribution. This could help boost vaccination rates in regions without adequate infrastructure for low-temperature storage.

4 Feb 2021

Sequential approach to treating comorbid PTSD and depression

This study is the first randomized control trial to rigorously test a sequential approach to treating comorbid PTSD and major depressive disorder.

4 Feb 2021

Finding ways to relieve painful intercourse

Researchers at Flinders University are working to remedy this situation by identifying what triggers this chronic pain in the female reproductive tract.

4 Feb 2021

What are public preferences for COVID-19 vaccine prioritization strategies across the globe?

Researchers describe the results of a novel survey that asked members of the public in a range of countries for their thoughts on prioritization measures for vaccination programs against COVID-19.

4 Feb 2021

Paternal early life stress linked to child's brain development

The FinnBrain research of the University of Turku has demonstrated for the first time that the stress the father has experienced in his childhood is connected to the development of the white matter tracts in the child's brain.

4 Feb 2021

South African SARS-CoV-2 variant neutralized by two Chinese vaccines in case study

A new study offers some reassuring findings, reporting the successful neutralization of the South African SARS-CoV-2 variant of concern (VOC) 501Y.V2 by two vaccines developed in China.

4 Feb 2021

Pfizer vaccine and Eli Lilly monoclonal antibodies successfully neutralize SARS-CoV-2 UK variant, finds study

A new study reports the underlying basis of increased transmissibility in the N501Y UK variant and provides reassuring data on the efficacy of the Pfizer vaccine and Eli Lilly monoclonal antibodies in neutralizing it.

4 Feb 2021

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

A new study server reports highly protective neutralizing monoclonal antibodies against the SARS-CoV-2.

4 Feb 2021

Medical Research News

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Research shows how air pollution has a detrimental impact on cardiovascular health

Seasonal flu shots reduce COVID-19 symptoms in children

Researchers call for trials of rapamycin to treat COVID-19

New guidance can help cardiac patients with diabetes to exercise more safely

School gardens may get children to eat more vegetables

Phase I/II trial findings support use of CoronaVac vaccine in older individuals

Race may play an important role in children's food allergies

New study to examine stress, cancer risk and reproductive toxicity in women firefighters

People with borderline personality disorder may have difficulty in accessing health services

New study supports UK’s delay of the SARS-CoV-2 Pfizer vaccine second dose

Cancer patients less likely to receive life-saving therapy when suffering a heart attack

Researchers develop thermostable RNA vaccine delivery platform

Sequential approach to treating comorbid PTSD and depression

Finding ways to relieve painful intercourse

What are public preferences for COVID-19 vaccine prioritization strategies across the globe?

Paternal early life stress linked to child's brain development

South African SARS-CoV-2 variant neutralized by two Chinese vaccines in case study

Pfizer vaccine and Eli Lilly monoclonal antibodies successfully neutralize SARS-CoV-2 UK variant, finds study

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News